Revenue: The sum of all revenue fields included for a company's operating activities.
Phathom Pharmaceuticals, Inc. (PHAT) had Revenue of $28.52M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$28.52M |
$-94.32M |
|
$3.72M |
|
$24.80M |
|
$107.38M |
|
$-78.86M |
|
$-15.45M |
|
$-94.32M |
|
$-94.32M |
|
$-94.32M |
|
$-94.32M |
|
$-94.32M |
|
$-94.32M |
|
$-78.86M |
|
$-77.99M |
|
71.97M |
|
71.97M |
|
$-1.31 |
|
$-1.31 |
|
| Balance Sheet Financials | |
$264.90M |
|
$1.35M |
|
$29.31M |
|
$294.21M |
|
$74.03M |
|
$203.25M |
|
$558.55M |
|
$632.58M |
|
$-338.38M |
|
$-338.38M |
|
$-338.38M |
|
69.64M |
|
| Cash Flow Statement Financials | |
$-84.93M |
|
$-0.02M |
|
-- |
|
$300.12M |
|
$215.18M |
|
$-84.95M |
|
$5.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.58 |
|
-- |
|
-- |
|
-1.50 |
|
-0.60 |
|
86.94% |
|
-276.53% |
|
-276.53% |
|
-- |
|
-330.71% |
|
-330.71% |
|
$-84.95M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
1.18 |
|
0.78 |
|
114.76 |
|
27.87% |
|
27.87% |
|
-32.06% |
|
69.80% |
|
$-4.86 |
|
$-1.18 |
|
$-1.18 |
|